Pulse Biosciences grants four new employees options to buy up to 6,300 shares
PLSE•Pulse Biosciences granted four new employees options covering up to 6,300 common shares on November 19, 2026, at an exercise price of $44.41 per share. The options vest in annual 25% installments over four years, subject to continued employment.
1. Option awards
The options were granted under the company’s 2017 Inducement Equity Incentive Plan and vest in annual installments of 25% over four years, subject to continued employment.




